glp-1 agonists anxiety side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Frontiers | GLP-1 Receptor Agonists:

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

The dual GIP/GLP-1 receptor agonist tirzepatide is among the furthest developed multi-agonists for diabetes care and has so far displayed promising nephroprotective effects

Glucocorticosteroids (GCs) are commonly used in the treatment of autoimmune, inflammatory and neoplastic diseases

Since most glucose-dependent insulinotropic polypeptide (GIP) receptor: glucagon-like peptide- 1 receptor (GLP- 1) receptor: glucagon receptor triagonists compete in efficacy with bariatric surgery, the success of these agents in preclinical models and clinical trials suggests a bright future for multi-agonists in the treatment of metabolic diseases

Both human and animal studies reported inconsistent BP response to acute administration but showed hypotensive effect of chronic administration of GLP-1/ GLP-1 RAs

Physician-supervised GLP-1 weight loss with Tirzepatide, offering personalized care in Glendale, La Caada and Burbank